[Drug utilization decisions should be based on cost-benefit data].
Bengt
Jönsson
J
Centrum för hälsoekonomi, Handelshögskolan i Stockholm.
Arvidsson
Göran
G
Levin
Lars-Ake
LA
Rehnberg
Claes
C
D003362:Cost-Benefit Analysis; D003657:Decision Making; D016527:Drug Costs; D011307:Drug Prescriptions / Q000191:economics*; D004363:Drug Utilization / Q000191:economics*; D019317:Evidence-Based Medicine; D006291:Health Policy; D006801:Humans